These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current. Witchel HJ, Hancox JC. Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966 [Abstract] [Full Text] [Related]
6. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current. Inanobe A, Kamiya N, Murakami S, Fukunishi Y, Nakamura H, Kurachi Y. J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804 [Abstract] [Full Text] [Related]
8. Facilitation of hERG Activation by Its Blocker: A Mechanism to Reduce Drug-Induced Proarrhythmic Risk. Furutani K. Int J Mol Sci; 2023 Nov 13; 24(22):. PubMed ID: 38003453 [Abstract] [Full Text] [Related]
10. Cardiac hERG K+ Channel as Safety and Pharmacological Target. Su S, Sun J, Wang Y, Xu Y. Handb Exp Pharmacol; 2021 Nov 13; 267():139-166. PubMed ID: 33829343 [Abstract] [Full Text] [Related]
11. [Progress in research on defective protein trafficking and functional restoration in HERG-associated long QT syndrome]. Fang P, Lian J. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb 13; 33(1):101-4. PubMed ID: 26829745 [Abstract] [Full Text] [Related]
13. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. Thomas D, Wendt-Nordahl G, Röckl K, Ficker E, Brown AM, Kiehn J. J Pharmacol Exp Ther; 2001 May 13; 297(2):753-61. PubMed ID: 11303067 [Abstract] [Full Text] [Related]
14. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs. Bai YL, Liu HB, Sun B, Zhang Y, Li Q, Hu CW, Zhu JX, Gong DM, Teng X, Zhang Q, Yang BF, Dong DL. J Mol Cell Cardiol; 2011 Nov 13; 51(5):876-80. PubMed ID: 21820442 [Abstract] [Full Text] [Related]
15. In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome. Romero L, Trenor B, Yang PC, Saiz J, Clancy CE. J Mol Cell Cardiol; 2014 Jul 13; 72():126-37. PubMed ID: 24631769 [Abstract] [Full Text] [Related]
17. The hERG channel activator, RPR260243, enhances protective IKr current early in the refractory period reducing arrhythmogenicity in zebrafish hearts. Shi YP, Pang Z, Venkateshappa R, Gunawan M, Kemp J, Truong E, Chang C, Lin E, Shafaattalab S, Faizi S, Rayani K, Tibbits GF, Claydon VE, Claydon TW. Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H251-H261. PubMed ID: 32559136 [Abstract] [Full Text] [Related]
18. Role of the activation gate in determining the extracellular potassium dependency of block of HERG by trapped drugs. Pareja K, Chu E, Dodyk K, Richter K, Miller A. Channels (Austin); 2013 Jan 01; 7(1):23-33. PubMed ID: 23221912 [Abstract] [Full Text] [Related]
19. hERG: protein trafficking and potential for therapy and drug side effects. Staudacher I, Schweizer PA, Katus HA, Thomas D. Curr Opin Drug Discov Devel; 2010 Jan 01; 13(1):23-30. PubMed ID: 20047143 [Abstract] [Full Text] [Related]
20. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3epsilon. Choe CU, Schulze-Bahr E, Neu A, Xu J, Zhu ZI, Sauter K, Bähring R, Priori S, Guicheney P, Mönnig G, Neapolitano C, Heidemann J, Clancy CE, Pongs O, Isbrandt D. Hum Mol Genet; 2006 Oct 01; 15(19):2888-902. PubMed ID: 16923798 [Abstract] [Full Text] [Related] Page: [Next] [New Search]